Development of Artificial Intelligence (AI) to accelerate Drug Target discovery
Not Applicable
Recruiting
- Conditions
- Interstitial Lung Disease including IPF (Idiopathic Pulmonary Fibrosis) Lung Cancer
- Registration Number
- JPRN-UMIN000041135
- Lead Sponsor
- ational Institutes of Biomedical Innovation, Health and Nutrition
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3700
Inclusion Criteria
Not provided
Exclusion Criteria
*Interstitial pneumonia including IPF (including suspicion) Patients who were judged to be unsuitable for participating in this study by the doctor in charge. *Lung cancer nothing special
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method